SBIO
ALPS Medical Breakthroughs ETF

SBIO$38.98
+$0.27
(+0.7%)
As of 3:59:30 PM EDT | 9/25/18  |  Market Closed

SBIO Trading Data

Open

$38.88

Low Price

$38.8

High Price

$39.14

Previous Last Price

$38.71

Bid Size

$36 X 500

Ask Size

$91 X 500

SBIO Portfolio Data

AUM

$282,656

Shares

7,300

PE Ratio

13.44

Price / Book Ratio

3.64

Expense Ratio

0.5

Net Asset Value

$38.72

Volume

Volume

66,446

Avg. Volume (YDT)

57,981

Dollar Volume

$2,475,279

Weekly Avg. Volume

54,060

Monthly Avg. Volume

52,995

Quarterly Avg. Volume

73,102

SBIO Fund Description

The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the Poliwogg Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.

SBIO Chart

SBIO Summary

Fund Family

ALPS Holdings

Tracks This Index

ALPS Medical Breakthroughs ETF

Inception Date

2015-01-05

Asset Class

Portfolio-Multi Asset

Asset Class Size

Healthcare

SBIO Classification

Region (General)

Global

Region (Specific)

Sector

Health Care

Equity Index

Leveraged Family

SBIO Holdings

Top 10 Holdings

GalapagosNV (GLPG)
3.77%
LigandPharmaceuticalsInc. (LGND)
3.55%
UnitedTherapeuticsCorp. (UTHR)
3.46%
FibroGenInc. (FGEN)
3.16%
LoxoOncologyInc. (LOXO)
3.14%
GWPharmaceuticalsPLC (GWPH)
3.03%
AgiosPharmaceuticalsInc. (AGIO)
2.76%
TaroPharmaceuticalIndustriesLtd. (TARO)
2.54%
ImmunomedicsInc. (IMMU)
2.51%
HutchisonChinaMediTechLtd. (HCM)
2.46%

Total SBIO Holdings

Total Holdings: 114

GalapagosNV (GLPG)
3.77%
LigandPharmaceuticalsInc. (LGND)
3.55%
UnitedTherapeuticsCorp. (UTHR)
3.46%
FibroGenInc. (FGEN)
3.16%
LoxoOncologyInc. (LOXO)
3.14%
GWPharmaceuticalsPLC (GWPH)
3.03%
AgiosPharmaceuticalsInc. (AGIO)
2.76%
TaroPharmaceuticalIndustriesLtd. (TARO)
2.54%
ImmunomedicsInc. (IMMU)
2.51%
HutchisonChinaMediTechLtd. (HCM)
2.46%
EndoInternationalPLC (ENDP)
2.34%
InterceptPharmaceuticalsInc. (ICPT)
2.19%
EmergentBioSolutionsInc. (EBS)
2.14%
MadrigalPharmaceuticalsInc. (MDGL)
2.1%
ArrayBioPharmaInc. (ARRY)
2.1%
HorizonPharmaPLC (HZNP)
2.03%
AeriePharmaceuticalsInc. (AERI)
1.71%
AcceleronPharmaInc. (XLRN)
1.69%
SupernusPharmaceuticalsInc. (SUPN)
1.65%
MyoKardiaInc. (MYOK)
1.64%
HalozymeTherapeuticsInc. (HALO)
1.64%
AscendisPharmaAS (ASND)
1.59%
HeronTherapeuticsInc. (HRTX)
1.58%
AkceaTherapeuticsInc. (AKCA)
1.55%
IronwoodPharmaceuticalsInc. (IRWD)
1.55%
AnaptysBioInc. (ANAB)
1.44%
ArenaPharmaceuticalsInc. (ARNA)
1.4%
PTCTherapeuticsInc. (PTCT)
1.37%
GlobalBloodTherapeuticsInc. (GBT)
1.34%
PaciraPharmaceuticalsInc. (PCRX)
1.34%
SparkTherapeuticsInc. (ONCE)
1.34%
MiratiTherapeuticsInc. (MRTX)
1.24%
G1TherapeuticsInc. (GTHX)
1.22%
AtaraBiotherapeuticsInc. (ATRA)
1.17%
EnantaPharmaceuticalsInc. (ENTA)
1.16%
AkornInc. (AKRX)
1.07%
InsmedInc. (INSM)
1.06%
TheravanceBiopharmaInc. (TBPH)
1.04%
AimmuneTherapeuticsInc. (AIMT)
1.03%
ImmunoGenInc. (IMGN)
0.87%
EndocyteInc. (ECYT)
0.79%
OmerosCorp. (OMER)
0.79%
ApellisPharmaceuticalsInc. (APLS)
0.72%
RhythmPharmaceuticalsInc. (RYTM)
0.71%
MacroGenicsInc. (MGNX)
0.61%
RevanceTherapeuticsInc. (RVNC)
0.6%
RocketPharmaceuticalsInc. (RCKT)
0.6%
AssemblyBiosciencesInc. (ASMB)
0.59%
IntersectENTInc. (XENT)
0.58%
AmarinCorp.PLC (AMRN)
0.57%
AcordaTherapeuticsInc. (ACOR)
0.56%
RadiusHealthInc. (RDUS)
0.53%
UroGenPharmaLtd. (URGN)
0.51%
FateTherapeuticsInc. (FATE)
0.5%
DynavaxTechnologiesCorp. (DVAX)
0.49%
NuCanaPLC (NCNA)
0.46%
EpizymeInc. (EPZM)
0.46%
AMAGPharmaceuticalsInc. (AMAG)
0.46%
MiMedxGroupInc. (MDXG)
0.46%
FlexionTherapeuticsInc. (FLXN)
0.45%
DovaPharmaceuticalsInc. (DOVA)
0.44%
CymabayTherapeuticsInc. (CBAY)
0.44%
ChemoCentryxInc. (CCXI)
0.42%
KuraOncologyInc. (KURA)
0.42%
GlycoMimeticsInc. (GLYC)
0.4%
VericelCorp. (VCEL)
0.39%
VoyagerTherapeuticsInc. (VYGR)
0.38%
OdonateTherapeuticsInc. (ODT)
0.37%
ArQuleInc. (ARQL)
0.36%
ProgenicsPharmaceuticalsInc. (PGNX)
0.35%
RaPharmaceuticalsInc. (RARX)
0.34%
AdamasPharmaceuticalsInc. (ADMS)
0.34%
MediciNovaInc. (MNOV)
0.32%
FivePrimeTherapeuticsInc. (FPRX)
0.32%
CASIPharmaceuticalsInc. (CASI)
0.32%
AduroBiotechInc. (ADRO)
0.32%
AchillionPharmaceuticalsInc. (ACHN)
0.31%
AkebiaTherapeuticsInc. (AKBA)
0.31%
MinervaNeurosciencesInc. (NERV)
0.31%
AclarisTherapeuticsInc. (ACRS)
0.3%
KiniksaPharmaceuticalsLtd. (KNSA)
0.3%
SyrosPharmaceuticalsInc. (SYRS)
0.28%
resTORbioInc. (TORC)
0.27%
CorbusPharmaceuticalsHoldingsInc. (CRBP)
0.26%
SavaraInc. (SVRA)
0.25%
AssertioTherapeuticsInc. (ASRT)
0.25%
AlbireoPharmaInc. (ALBO)
0.24%
MarinusPharmaceuticalsInc. (MRNS)
0.23%
PDLBioPharmaInc. (PDLI)
0.23%
CoriumInternationalInc. (CORI)
0.22%
CatalystPharmaceuticalsInc. (CPRX)
0.21%
ConcertPharmaceuticalsInc. (CNCE)
0.2%
ParatekPharmaceuticalsInc. (PRTK)
0.2%
TocagenInc. (TOCA)
0.18%
AthersysInc. (ATHX)
0.17%
KalaPharmaceuticalsInc. (KALA)
0.17%
ArdelyxInc. (ARDX)
0.17%
IderaPharmaceuticalsInc. (IDRA)
0.15%
JounceTherapeuticsInc. (JNCE)
0.14%
AllenaPharmaceuticalsInc. (ALNA)
0.14%
StrongbridgeBiopharmaPLC (SBBP)
0.13%
ClearsideBiomedicalInc. (CLSD)
0.13%
LannettCo.Inc. (LCI)
0.13%
CalitheraBiosciencesInc. (CALA)
0.12%
AvadelPharmaceuticalsPLC (AVDL)
0.11%
DurectCorp. (DRRX)
0.11%
ImmuneDesignCorp. (IMDZ)
0.11%
SyndaxPharmaceuticalsInc. (SNDX)
0.1%
CatalystBiosciencesInc. (14888D20)
0.08%
CTIBioPharmaCorp. (CTIC)
0.07%
AquinoxPharmaceuticalsInc. (AQXP)
0.04%
State StreetInstitutionalTreasuryPlusMoneyMarketFund (TPIXX)
0.03%
CashandEquivalents
0.01%
ALPS Medical Breakthroughs ETF (SBIO)
0%

SBIO Technicals

Alpha

-2.91

Beta

1.9

Leverage

Long

Standard Deviation

3.18

SBIO Dividends

Dividend Date

2017-12-21

Latest Dividend

0.579

Annual Dividend

0.58

Annual Dividend Rate

0.58

Annual Dividend Yield

1.5

SBIO Performance

YTD Return

18.88%

1 Year Return

26.35%

3 Year Return

30.6%

5 Year Return

0%

10 Year Return

55.84%

SBIO Related Articles

A Nifty Biotech ETF Idea for 2018

A Nifty Biotech ETF Idea for 2018

Biotechnology stocks bolstered the broader healthcare sector last year, a theme that is expected to continue in 2018. Investors looking for a way to access potentially smaller biotechnology companies can…

Biotech ETFs Jump on Gilead, Kite Deal

Biotech ETFs Jump on Gilead, Kite Deal

The biotechnology segment rallied Monday with small-cap biotech names and related exchange traded funds leading the charge after Gilead Sciences (NasdaqGS: GILD) acquired Kite Pharma (NasdaqGS: KITE). The iShares Nasdaq…

ETF Performance Report: February 2017

ETF Performance Report: February 2017

U.S. equities and stock exchange traded funds ended February on a sullen note, with the Dow Jones Industrial Average snapping a 12-day winning streak, as cautious investors await President Donald…

Healthcare ETFs Are Latest Victim to Trump

Healthcare ETFs Are Latest Victim to Trump

Healthcare stocks, especially the biotech segment, and related exchange traded funds plunged Wednesday after President-elect Donald Trump singled out the rising drug prices at a press conference. The healthcare sector…